Commentary: Adjuvant therapy in resected T1 2N0 non-small cell lung cancer: Surgeons should lead. Chudgar NP, Stiles BM. J Thorac Cardiovasc Surg 2021 Jul 14. pii: S0022-5223(21)01036.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chudgar NP, Stiles BM. Commentary: Adjuvant therapy in resected T1 2N0 non-small cell lung cancer: Surgeons should lead. J Thorac Cardiovasc Surg 2021 Jul 14. pii: S0022-5223(21)01036.
PMID: 34417042